Modulation by α-difluoromethyl-ornithine and aminoguanidine of pain threshold, morphine analgesia and tolerance

European Journal of Pharmacology

Volumn 478, Issue 2-3, 2003, Pages 139-144

  Lu, Gang ^a   Su, Rui Bin ^a   Li, Jin ^a   Qin, Bo Yi ^a  

^a BEIJING INSTITUTE OF PHARMACOLOGY AND TOXICOLOGY   (China)

Author keywords

Agmatine; Aminoguanidine; Analgesia; Morphine; Tolerance; Difluoromethyl ornithine

Indexed keywords

AGMATINE; AMINOGUANIDINE; EFLORNITHINE; IDAZOXAN; IMIDAZOLINE RECEPTOR; MORPHINE; NITRIC OXIDE SYNTHASE;

ANALGESIA; ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; ENZYME INHIBITION; FEMALE; IN VIVO STUDY; MALE; METABOLISM; MORPHINE TOLERANCE; MOUSE; NONHUMAN; PAIN; PAIN THRESHOLD; PRIORITY JOURNAL; TAIL FLICK TEST; TASK PERFORMANCE; WRITHING TEST;

EID: 0142231063     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2003.08.048     Document Type: Article

References (23)

1. Babey A.M., Kolesnikov Y., Cheng J., Inturrisi C.E., Trifilletti R.R., Pasternak G.W. Nitric oxide and opioid tolerance. Neuropharmacology. 33:1994;1463-1470.
2. Corbett J.A., Tilton R.G., Chang K., Hasan K.S. Aminoguanidine, a novel inhibitor of nitric oxide formation, prevents diabetic vascular dysfunction. Diabetes. 41:1992;552-556.
3. Galea E., Regunathan S., Eliopoulos V., Feinstein D.L., Reis D.J. Agmatine, a bioactive metabolite of arginine. Production, degradation, and functional effects in the kidney of the rat. J. Clin. Invest. 97:1996;413-420.
4. Garthwaite J., Boulton C.L. Nitric oxide signaling in the central nervous system. Annu. Rev. Physiol. 57:1995;683-706.
5. Genedani S., Bernardi M., Tagliavini S., Bertolini A. ODC-polyamine system is involved in morphine analgesia. Life Sci. 44:1989;525-531.
6. Hasan K., Heesen B.-J., Corbett J.A., McDaniel M.L. Inhibition of nitric oxide formation by guanidines. Eur. J. Pharmacol. 249:1993;101-106.
7. Hernandez S., Schwarcz de Tarlovsky S. Arginine decarboxylase in Trypanosoma cruzi, characteristics and kinetic properties. Cell Mol. Biol. (Noisy-le-grand). 45:1999;383-391.
8. Holt A., Baker G.B. Metabolism of agmatine (clonidine-displacing substance) by diamine oxidase and the possible implications for studies of imidazoline receptors. Prog. Brain Res. 106:1995;187-197.
9. Hu W.H., Sun X.J., Wan X.C., Liu J.S. NOS inhibitor L-NAME produces analgesia, hyperalgesia and paralysis in rats. Chin. Pharmacol. Bull. 12:1996;309-313.
10. Kolesnikov Y., Jain S., Pasternak G.W. Modulation of opioid analgesia by agmatine. Eur. J. Pharmacol. 296:1996;17-22.
11. Li G., Regunathan S., Barrow C.J., Eshraghi J., Cooper R., Reis D.J. Agmatine: an endogenous clonidine-displacing substance in the brain. Sci. 263:1994;966-969.
12. Li J., Li X., Pei G., Qin B.Y. Analgesic effect of agmatine and its enhancement on morphine analgesia in mice and rats. Acta Pharmacol. Sin. 20:1999;81-85.
13. Li J., Li X., Pei G., Qin B.Y. Effects of agmatine on tolerance to and substance dependence on morphine in mice. Acta Pharmacol. Sin. 20:1999;232-238.
14. Moss D.W., Wei X., Liew F.Y., Moncada S. Enzymatic characterization of recombinant murine inducible nitric oxide synthase. Eur. J. Pharmacol. 289:1995;41-43.
15. Pataki I., Telegdy G. Further evidence that nitric oxide modifies acute and chronic morphine actions in mice. Eur. J. Pharmacol. 357:1998;157-162.
16. Pelligrino D.A., Laurito C.E., VadeBoncouer T.R. Nitric oxide synthase inhibition modulates the ventilatory depressant and antinociceptive actions of fourth ventricular infusions of morphine in the awake dog. Anesthesiology. 85:1996;1367-1377.
17. Reis D.J., Regunathan S. Agmatine: a novel neurotransmitter? Adv. Pharmacol. 42:1998;645-649.
18. Reis D.J., Regunathan S. Is agmatine a novel neurotransmitter in brain? Trends Pharmacol. Sci. 21:2000;187-193.
19. Selamnia M., Mayeur C., Robert V., Blachicr F. Alpha- difluoromethylornithine (DFMO) as a potent arginase activity inhibitor in human colon carcinoma cells. Biochem. Pharmacol. 55:1998;1241-1245.
20. Slotkin T.A., Seidler F.J., Trepanier P.A., Whitmore W.L., Lerea L., Barnes G.A., Weigel S.J., Bartolome J. Ornithine decarboxylase and polyamines in tissues of the neonatal rat: effects of alpha-difluoromethylornithine, a specific, irreversible inhibitor of ornithine decarboxylase. J. Pharmacol. Exp. Ther. 222:1982;741-745.
21. Su R.B., Li J., Gao K., Pei G., Qin B.Y. Influence of idazoxan on analgesia, tolerance, and physical dependence of morphine in mice and rats in vivo. Acta Pharmacol. Sin. 21:2000;1011-1015.
22. Su R.B., Li J., Li X., Qin B.Y. Down-regulation of MAO-B activity and imidazoline receptors in rat brain following chronic treatment of morphine. Acta Pharmacol. Sin. 22:2001;639-644.
23. Su R.B., Li J., Qin B.Y. Effects of spermine and spermidine on morphine analgesia. Bull. Acad. Mil. Med. Sci. 27:2003;123-125.